# Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Tenecteplase (RITIS-TNK2)

> **NCT07375966** · PHASE2 · RECRUITING · sponsor: **General Hospital of Shenyang Military Region** · enrollment: 198 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Tenecteplase

## Key facts

- **NCT ID:** NCT07375966
- **Lead sponsor:** General Hospital of Shenyang Military Region
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-25
- **Primary completion:** 2027-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 198 (ESTIMATED)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07375966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07375966, "Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Tenecteplase (RITIS-TNK2)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07375966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*